A 'hybrid' therapy for Parkinson's disease developed by Remepy, combining a drug with a digital therapeutic, has shown efficacy in a phase 2 proof-of-concept trial
[282] demonstrated that transitioning from a Western dietary pattern to a Mediterranean diet, while maintaining consistent energy intake, macronutrient distribution, and levels of physical activity, significantly influences individual clinical outcomes, as well as the gut microbiome and metabolome, after a four-week intervention period in a population exhibiting cardiometabolic risk associated with an unhealthy lifestyle [282]
Originally developed for diabetes management, this compound has demonstrated notable efficacy in weight loss applications, leading to its widespread adoption in metabolic health protocols
For instance, the synergistic impact of persistent antigen stimulation, hypoxia, and glucose deprivation promotes the perpetual activity of acetyl-CoA carboxylase 1 (ACC1) to block FAO, leading to energy crisis and accelerated T-cell exhaustion [59]
Amylin Biology: The Context for Cagrilintide Research Understanding cagrilintide requires understanding amylins role in metabolic physiology
